Alliance for Vascular Access Teaching and Research - Avatar Group

Attention all healthcare professionals!

Up to 70% of emergency department patients and 80% of hospital admissions require an IV drip. Enhancing your skills in peripheral intravenous catheter insertion can make a significant difference in patient care.

Explore our new Difficult IV Access (DIVA) Resources page for valuable information and tools to help you improve your IV insertion techniques: https://www.avatargroup.org.au/diva-key--clinician.html

DIVA Key: Clinician Diva

Embrace the future of pediatric care with Interrad Medical’s SecurAcath!

Our groundbreaking study, featured in JAMA Pediatrics, reveals SecurAcath reduces catheter dislodgement rates by an impressive 4.4 times compared to traditional adhesives. Not only does it enhance patient safety, but it also offers substantial cost savings per use.

Join us in revolutionizing medical innovation and improving outcomes for young patients worldwide.

Click here to read more: https://www.businesswire.com/news/home/20240716891379/en/Interrad-Medical%E2%80%99s-SecurAcath-is-Superior-to-Standard-of-Care-in-Newly-Published-Randomized-Controlled-Clinical-Study

Interrad Medical’s SecurAcath is Superior to Standard of Care in Newly Published Randomized Controlled Clinical Study Interrad Medical, Inc., a privately held medical device company, announces excellent results of a clinical study published in JAMA Pediatrics titled,

Don't miss out on AVASM24!

Join us in Denver, CO from September 28-30, 2024, for an incredible in-person experience filled with education, networking, and fun!
Can't make it to Denver? No worries! Register for AVA On-Demand starting October 14, 2024.

Presenter: Kerrie A. Curtis, RN, MN - Cancer/Palliative Care, PhD Candidate

Date/Time: Monday, September 30, 2024 / 7:30 AM – 8:30 AM MST

Topic: (I5) Part 1: Multi-site Retrospective Cohort Study of Central Venous Access Device Removal in Patients with Haematology Cancers Part 2: Evaluating Outcomes and Impact of Implanted Venous Port Removal by an Advanced Practice Provider Lead Team

Secure your spot now and elevate your professional journey: https://bit.ly/3Rwhjte

📢 Attention Healthcare Professionals! 📢

Are you involved in the use of peripherally inserted central catheters (PICCs)?

Discover the latest research on the effectiveness of different PICC materials and designs in reducing catheter failure and complications. This comprehensive review evaluates outcomes such as venous thromboembolism, bloodstream infections, occlusion, and more, providing crucial insights to enhance patient care. Stay informed and optimize your clinical practice with evidence-based findings!

Read the full study now to explore the impact of integrated valve technology, anti-thrombogenic surface modification, and antimicrobial impregnation on PICC performance: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013366.pub2/full

Peripherally inserted central catheter design and material for reducing catheter failure and complications - Schults, JA - 2024 | Cochrane Library Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in About Cookies.

Don't miss out on AVASM24!

Join us in Denver, CO from September 28-30, 2024, for an incredible in-person experience filled with education, networking, and fun!
Can't make it to Denver? No worries! Register for AVA On-Demand starting October 14, 2024.

Presenter: Kerrie A. Curtis, RN, MN - Cancer/Palliative Care, PhD Candidate

Date/Time: Sunday, September 29, 2024 / 4:45 PM – 5:45 PM MST

Topic: (H3) A Global Challenge: CVAD Nomenclature, Taxonomy for Complications, and Removal in Oncology: A Scoping Review

Secure your spot now and elevate your professional journey: https://bit.ly/3Rwhjte

Check Out the AVATAR July 2024 Newsletter!

We've got exciting updates, exclusive insights, and more in this month's edition of the AVATAR newsletter. Dive in to learn about our latest research, events, and innovations in the world of vascular access. Don't miss out!

🔗 Read the full AVATAR July 2024 Newsletter here: https://sway.cloud.microsoft/kI5XPjcETbLmyoZD?ref=Link

Stay informed and engaged with the latest from AVATAR.

AVATAR July 2024 Newsletter From Prof Sam Keogh:

The Dynamic Duo are back! You don't want to miss this one!

Join us in Denver, CO from September 28-30, 2024, for an incredible in-person experience filled with education, networking, and fun!
Can't make it to Denver? No worries! Register for AVA On-Demand starting October 14, 2024.

Presenters: Andrew C. Bulmer, PhD & Rhys L. Pritchard, PhD

Date/Time: Sunday, September 29, 2024 / 9:45 AM – 10:45 AM MST

Topic: (E2) General Session: IMpact of catheter stabilizatiOn on caTheter mIcrO-motioN and function (MOTION study)

Secure your spot now and elevate your professional journey: https://bit.ly/3Rwhjte

Discover how we've enhanced patient safety in Brazil by translating and adapting the I-DECIDED® tool into Portuguese for peripheral intravenous catheters.

Validated and reliable, this tool is now empowering Brazilian nurses to make better clinical decisions. Curious to learn more?

Dive into our latest update: https://www.scielo.br/j/tce/a/Mkh9gB84pC9YpTGz6zZwk3d/?lang=en

Send a message to learn more

Don't miss out on AVASM24!

Join us in Denver, CO from September 28-30, 2024, for an incredible in-person experience filled with education, networking, and fun!
Can't make it to Denver? No worries! Register for AVA On-Demand starting October 14, 2024.

Presenter: Evan Alexandrou, RN MPH PhD

Date/Time: Monday, September 30, 2024 / 7:30 AM – 8:30 AM MST

Topic: (I4) Unravelling the Nuances: Comparing FICCs with PICCs for Intermediate Long-Term Solutions

Secure your spot now and elevate your professional journey: https://bit.ly/3Rwhjte

Survey Extended 📣

A pivotal survey on haemodialysis catheter care in ICUs is underway, and your insights are invaluable. This research aims to enhance care practices, reduce complications, and improve patient outcomes, and it needs your expertise.

Why Your Voice Matters:
Drive improvements in haemodialysis catheter care.
Quick participation: Only 20 minutes.
Ethically approved & anonymous.

Share your insights today - https://lnkd.in/gsz-MuuN

Let's contribute to safer patient care together.

hashtag hashtag hashtag hashtag

Arterial catheters (ACs) are vital for haemodynamic monitoring and blood sampling but often face complications. This study investigates the incidence and risk factors of AC failure in ICU patients.

Key Findings:

- 26% of patients experienced AC failure.
- Suspected catheter-associated bloodstream infection (CABSI) was the most common failure type.
- Ultrasound-assisted insertion significantly reduced failure rates.
- Increased age and certain demographics influenced failure risk.
- Discover the full insights and implications for improving AC management in critical care.

Read More: https://pubmed.ncbi.nlm.nih.gov/38459599/

Risk factors for arterial catheter failure and complications during critical care hospitalisation: a secondary analysis of a multisite, randomised trial - PubMed AC failure is common with ultrasound-guided insertion associated with lower failure rates. Trial registration Australian New Zealand Clinical Trial Registry (ACTRN 12610000505000); date registered: 18 June 2010.

🚨 Call for Papers 🚨

Antimicrobial Resistance & Infection Control invites submissions to our Collection on Safe Intravascular Catheters: Finding and Preventing Bloodstream Infections.

Effective healthcare relies on the safe use of intravascular catheters. Help us address this crucial aspect by contributing your research on:

🔹 Optimal catheter choice
🔹 Safe insertion and maintenance
🔹 Timely removal and patient partnership
🔹 Surveillance and risk factor identification
🔹 Novel medical devices and clinical practices

Join us in enhancing catheter safety across all patient populations. Submit your original research, reviews, brief reports, and commentaries.

Learn more and submit: www.biomedcentral.com/collections/SIVC

Cross-continental collaboration: Australia and France bring the ProP Trial's innovative antimicrobial dressing to life. Don't miss out on AVASM24!

Join us in Denver, CO from September 28-30, 2024, for an incredible in-person experience filled with education, networking, and fun!
Can't make it to Denver? No worries! Register for AVA On-Demand starting October 14, 2024.

Presenters: Claire M. Rickard, RN PhD & Bertrand Drugeon, MD, PhD (candidate)

Date/Time: Saturday, September 28, 2024 / 3:00 PM – 4:00 PM MST

Topic: (C1) A Pilot Randomized Control Trial of a Novel Antimicrobial Dressing in Peripheral Intravenous Catheters: The ProP Trial

Secure your spot now and elevate your professional journey: https://bit.ly/3Rwhjte

Healthcare Workers in the Greater Brisbane area: Looking to Develop your Ultrasound-guided PIVC skills?

Target Audience
Healthcare workers who are competent in peripheral intravenous cannulation and would like to develop their skills in ultrasound guided peripheral intravenous cannulation.

Course Description
This blended learning course provides the fundamental knowledge and practical skills for when ultrasound is required to gain peripheral intravenous access. The course consists of an online learning course and a face-to-face workshop.

Places are limited!

Find out more: https://bit.ly/4eFglou

Are we striking the right balance between reducing infection risks and minimizing waste in ICUs?

The latest study examines current guidelines for changing infusion sets connected to central venous catheters (CVCs) in Australian and New Zealand intensive care units (ICUs). Surprisingly, while recent evidence supports extending the replacement period to 7 days without increasing infection risks, only one-third of ICUs have adopted this practice.

Dive into the details of our prospective cross-sectional study and discover how we can improve both patient safety and environmental sustainability in healthcare: https://pubmed.ncbi.nlm.nih.gov/37385895/

How often are infusion sets for central venous catheters changed in Australian and New Zealand Intensive Care Units? A point prevalence survey - PubMed Most ICUs participating in this survey had policies to change their CVC infusion tubing in 3-4 days, and recent high-level evidence supports an update to extend this to 7 days. There remains work to be done to spread this evidence to ANZ ICUs and improve environmental sustainability initiatives.

Join Us at ASUM 24 in Brisbane!

The Australasian Society for Ultrasound in Medicine (ASUM) invites you to our annual conference at the W Hotel in Brisbane, November 1-3, 2024. Connect with top experts, attend interactive workshops, and explore cutting-edge research.

Register now: https://asum.eventsair.com/asum-24

See you there!

Healthcare professionals interested in mastering PICC insertion are invited to a special 2-hour workshop. Led by Vascular Access Specialists from various hospitals, the workshop will cover:

🔹 Vein Selection and Proper Assessment
🔹 Tip Navigation System (ECG Guidance)
🔹 Insertion Location
🔹 Needle Tracking
🔹 Line Length and Trimming
🔹 Best Tip Position
🔹 Securement Techniques
🔹 And more!

📅 Date: 25th July 2024
⏰ Time: 17:00 - 19:00 AEST
📍 Location: St Vincent's Hospital, Douglas Miller Lecture Theatre, Darlinghurst, NSW

To register, scan the barcode or email [email protected].

Critical Findings on CVAD Failure

The recent study highlights that 10.2% of central venous access devices (CVADs) fail before therapy is complete. Major complications include CLABSI, occlusion, and dislodgement. Key risk factors are blood product administration through PICCs, fewer lumens in TCVADs, chemotherapy, and diabetes. Protective measures such as antimicrobial NTCVADs and lipid administration in TCVADs can help.

Understanding these factors is crucial for improving patient outcomes. Read more about our findings and recommendations in the full study: https://pubmed.ncbi.nlm.nih.gov/38800854/

Incidence and risk factors for central venous access device failure in hospitalized adults: A multivariable analysis of 1892 catheters - PubMed In 1892 CVADs, all-cause failure occurred in 10.2% of devices: 49 NTCVADs (6.1%); 100 PICCs (13.2%); 44 TCVADs (13.4%). Failure rates for CLABSI, occlusion and dislodgement were 5.3%, 1.8%, and 1.7%, respectively. Independent CLABSI predictors were blood product administration through PICCs (hazard....

Call for Abstracts Closing Soon!

Submit your research, innovative programs, and findings for the 2024 ACIPC International Conference by 14 June.

Presentation types:
🔹 Scientific Oral Presentations
🔹 Case Studies & Quality Improvement
🔹 Lightning Talks
🔹 Posters

Don’t miss this chance to share your expertise and connect with peers! Visit the website to submit your abstract: https://acipcconference.com.au/abstracts/

Abstract Submission We invite you to submit an abstract for presentation at the 2024 Australasian College for Infection and Prevention Control (ACIPC) International Conference being held from 17 – 20 November in Melbourne.

Bonjour!

Discover the inspiring journey of Rebecca, Bertrand, and their baby Ava as they embrace a year in Brisbane with the AVATAR group!

Read the full blog to join their adventure and get inspired: https://www.avatargroup.org.au/blog/introducing-rebecca-and-bertrand-drugeon--a-journey-from-france-to-australia-with-avatar

Introducing Rebecca and Bertrand Drugeon: A Journey from Fra Bonjour! My name is Rebecca Drugeon, I'm from France, and Ive come to Brisbane for 1 year with my husband, Bertrand, and our 6-month-old baby, Ava. We are curren

A pivotal survey on haemodialysis catheter care in ICUs is underway, and your insights are invaluable. This research aims to enhance care practices, reduce complications, and improve patient outcomes, and it needs your expertise.

Why Your Voice Matters:
Drive improvements in haemodialysis catheter care.
Quick participation: Only 20 minutes.
Ethically approved & anonymous.

Share your insights today - https://redcap.link/haemodialysis_cath_survey

Let's contribute to safer patient care together.

Explore the Latest Research in Vascular Access: AVATAR Publications 2023

Dive into cutting-edge insights and advancements in vascular access care through the publications of the AVATAR group.

Discover a wealth of knowledge from prominent researchers and clinicians in the field: https://www.avatargroup.org.au/our-publications.html

Read our research AVATAR Publications vascular access IV

Explore CVAD Resources for Patients!

Discover a wealth of patient information on Central Venous Access Devices (CVAD) through our collaboration with eviQ and Cancer Institute NSW. Empower yourself with insights into various treatments using CVADs: https://www.avatargroup.org.au/cvad-resources-for-patients.html?_token=42097dd62fc1d31c3a4dd04532439aa8

Share this resource with others who may benefit from a deeper understanding of CVADs!

Step into the future of vascular access care with AVATAR! Did you know AVATAR is on a mission to make vascular access complications history?

Our research findings are already transforming healthcare, improving patient outcomes, and saving millions.

Join us in creating a world where vascular access complications are a thing of the past: https://www.avatargroup.org.au/

Explore AVATAR now and shape the future of healthcare!

The AVATAR Group: Health and Medical Research AVATAR: Making Vascular Access Complications History

Unlock the Power of Knowledge! Dive into our extensive library of cutting-edge videos and webinars presented by industry experts: https://www.avatargroup.org.au/multimedia-learning-resources.html

From evidence-based lists of vesicant medications to essential practices for CVAD infection prevention, we've got it all. Elevate your skills, stay informed, and shape the future of healthcare.

Multimedia Learning Resources multimedia learning resources

We're thrilled to announce that AVATAR has reached an incredible milestone with 2,500 clicks in just 28 days!

We're excited to share some insights about the most visited pages on our website:

1. AVATAR Home: Our homepage is where it all begins, showcasing the latest updates, news, and initiatives: https://www.avatargroup.org.au/

2. Pivotal PIVC Blood Sampling: A deep dive into the world of PIVC blood sampling: https://www.avatargroup.org.au/blog/pivc-blood-sampling

3. Crucial Insights on Central Line Bloodstream Infections (CLABSI or CRBSI): https://www.avatargroup.org.au/blog/central-line-bloodstream-infections--clabsi-or-crbsi-

As we celebrate this achievement, stay tuned for more insightful content, updates, and initiatives from AVATAR.

Launch Event: Vessel Health and Preservation

In 2021, we launched the first topic of the new CNSA Vascular Access Guidelines focused on patency, occlusion prevention and management. The second topic Vessel Health and Preservation incorporates device selection and difficult intravenous access through an oncology lens.

https://www.cnsa.org.au/events/event/launch-event-vessel-health-and-preservation

Registration: FREE

Date: Tuesday 19 March 2024
WA: 4:00pm - 5:30pm
SA: 6:30pm – 8:00pm
NT: 5:30pm - 7:00pm
QLD 6:00pm - 7:30pm
NSW / VIC / TAS / ACT: 7:00pm - 8:30pm

CPD: 1.5 CPD Hour

An innovative research project at QEII Hospital will explore whether the use of virtual reality can help reduce anxiety for patients who present to the emergency department (ED).
https://www.pafoundation.org.au/blog/calming-emergency-patients-with-virtual-reality
Grace Xu

Dive into essential research with Godelieve Goossens, a seasoned Clinical Nurse Specialist boasting over a decade of expertise at UZ Leuven. She has embarked on a crucial research project focusing on the flushing and locking procedures of venous access devices.

Join Godelieve in a survey conducted in collaboration with the Vascular Access Research Team at University Hospitals Leuven, Belgium. Your insights will play a pivotal role in shaping the future of nursing practices.

The survey only takes 10-20 minutes to complete, and your efforts will make a significant impact.

Survey Link: https://kuleuven.eu.qualtrics.com/jfe/form/SV_5AvS98SpOKU8ylU

Flushing and locking survey A survey which investigates how many hospitals are currently working HEPARIN FREE for intravenous catheters and explore flushing and locking procedures